Rad AI raised its Series C funding to $68 million, with $8 million from top U.S. health systems.
Key Details
- 1Advocate Health, Memorial Hermann, Corewell Health, and Atlantic Health System invested a combined $8 million.
- 2The total fundraising for Rad AI's Series C is $68 million.
- 3Rad AI's solutions reportedly impact nearly half of all imaging volumes in the U.S.
- 4The company achieved 8,710% revenue growth from 2020-2023.
- 5Rad AI is valued at $525 million according to Pitchbook estimates.
- 6The investment aims to drive systemwide adoption of radiology AI and address clinical and operational pressures.
Why It Matters
Such large-scale investment by major health systems signals growing confidence in radiology-focused AI solutions and supports further innovation and adoption. This collaboration could accelerate AI integration across the imaging workflow, with potential improvements in patient care and operational efficiency.
Source
Radiology Business
Related News
•Radiology Business
Aidoc Receives FDA Breakthrough Status for Multi-Condition CT AI Triage
Aidoc has received FDA Breakthrough Device status for its AI solution that flags multiple critical conditions in CT scans.
•AI in Healthcare
FDA Seeks Real-World Performance Insights on AI Medical Devices
FDA calls for healthcare worker feedback to enhance monitoring of AI-enabled medical devices in real-world settings.
•Health Imaging
Most FDA-Cleared AI Devices Lack Pre-Approval Safety Data, Study Finds
A new study finds fewer than 30% of FDA-cleared AI medical devices reported key safety or adverse event data before approval.